Skip to main content
. 2021 May 7;9(5):e002198. doi: 10.1136/jitc-2020-002198

Figure 2.

Figure 2

Consolidated Standards of Reporting Trials diagram. IHC, immunohistochemistry; WSG-ADAPT-TN, the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer trial.